<DOC>
	<DOCNO>NCT02356289</DOCNO>
	<brief_summary>The purpose study establish initial safety , tolerability , pharmacokinetics pharmacodynamics MYK-461 human subject . This randomized , double-blind , placebo-controlled , sequential group , single ascending ( oral ) dose study healthy volunteer age 18-55 year .</brief_summary>
	<brief_title>Single Ascending Dose Study MYK-461 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Normal body mass index ( BMI ) Normal LVEF Normal electrocardiogram ( ECG ) Females must breastfeed must permanently sterilize postmenopausal . Any structural abnormality echocardiography Positive result HIV test and/or seropositive HCV HBV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Hypertrophic Cardiomyopathy</keyword>
</DOC>